Literature DB >> 28450437

Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.

T J Rath1,2, S Narayanan3, M A Hughes4,2, R L Ferris2, S I Chiosea5, B F Branstetter4,2.   

Abstract

BACKGROUND AND
PURPOSE: Human papillomavirus-related oropharyngeal squamous cell carcinoma is associated with cystic lymph nodes on CT and has a favorable prognosis. A subset of patients with aggressive disease experience treatment failure. Our aim was to determine whether the extent of cystic lymph node burden on staging CT can serve as an imaging biomarker to predict treatment failure in human papillomavirus-related oropharyngeal squamous cell carcinoma.
MATERIALS AND METHODS: We identified patients with human papilloma virus-related oropharyngeal squamous cell carcinoma and staging neck CTs. Demographic and clinical variables were recorded. We retrospectively classified the metastatic lymph node burden on CT as cystic or solid and assessed radiologic extracapsular spread. Biopsy, subsequent imaging, or clinical follow-up was the reference standard for treatment failure. The primary end point was disease-free survival. Cox proportional hazard regression analyses of clinical, demographic, and anatomic variables for treatment failure were performed.
RESULTS: One hundred eighty-three patients were included with a mean follow-up of 38 months. In univariate analysis, the following variables had a statistically significant association with treatment failure: solid-versus-cystic lymph nodes, clinical T-stage, clinical N-stage, and radiologic evidence of extracapsular spread. The multivariate Cox proportional hazard model resulted in a model that included solid-versus-cystic lymph nodes, T-stage, and radiologic evidence of extracapsular spread as independent predictors of treatment failure. Patients with cystic nodal metastasis at staging had significantly better disease-free survival than patients with solid lymph nodes.
CONCLUSIONS: In human papilloma virus-related oropharyngeal squamous cell carcinoma, patients with solid lymph node metastases are at higher risk for treatment failure with worse disease-free survival. Solid lymph nodes may serve as an imaging biomarker to tailor individual treatment regimens.
© 2017 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28450437      PMCID: PMC7959900          DOI: 10.3174/ajnr.A5177

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

2.  Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence.

Authors:  Jessica H Maxwell; Bhavna Kumar; Felix Y Feng; Francis P Worden; Julia S Lee; Avraham Eisbruch; Gregory T Wolf; Mark E Prince; Jeffrey S Moyer; Theodoros N Teknos; Douglas B Chepeha; Jonathan B McHugh; Susan G Urba; Jay Stoerker; Heather M Walline; David M Kurnit; Kitrina G Cordell; Samantha J Davis; Preston D Ward; Carol R Bradford; Thomas E Carey
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

3.  Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.

Authors:  Brian O'Sullivan; Shao Hui Huang; Lillian L Siu; John Waldron; Helen Zhao; Bayardo Perez-Ordonez; Ilan Weinreb; John Kim; Jolie Ringash; Andrew Bayley; Laura A Dawson; Andrew Hope; John Cho; Jonathan Irish; Ralph Gilbert; Patrick Gullane; Angela Hui; Fei-Fei Liu; Eric Chen; Wei Xu
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

4.  Extracapsular spread in head and neck carcinoma: impact of site and human papillomavirus status.

Authors:  Jessica H Maxwell; Robert L Ferris; William Gooding; Diana Cunningham; Vikas Mehta; Seungwon Kim; Eugene N Myers; Jonas Johnson; Simion Chiosea
Journal:  Cancer       Date:  2013-06-24       Impact factor: 6.860

5.  Accuracy of computed tomography in the prediction of extracapsular spread of lymph node metastases in squamous cell carcinoma of the head and neck.

Authors:  Raymond L Chai; Tanya J Rath; Jonas T Johnson; Robert L Ferris; Gregory J Kubicek; Umamaheswar Duvvuri; Barton F Branstetter
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2013-11       Impact factor: 6.223

6.  Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon.

Authors:  David Goldenberg; Shahnaz Begum; William H Westra; Zubair Khan; James Sciubba; Sara I Pai; Joseph A Califano; Ralph P Tufano; Wayne M Koch
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

7.  Highly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics.

Authors:  Azeem S Kaka; Bhavna Kumar; Pawan Kumar; Paul E Wakely; Claudia M Kirsch; Matthew O Old; Enver Ozer; Amit Agrawal; Ricardo E Carrau; David E Schuller; Farzan Siddiqui; Theodoros N Teknos
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-06-14

8.  High-risk human papillomavirus and lymph node size in patients with single node metastasis of oral and oropharyngeal cancer.

Authors:  Young-Hoon Joo; Kwang-Jae Cho; Jun-Ook Park; In-Chul Nam; Chung-Soo Kim; Min-Sik Kim
Journal:  Acta Otolaryngol       Date:  2014-04       Impact factor: 1.494

9.  Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.

Authors:  Maura L Gillison; Qiang Zhang; Richard Jordan; Weihong Xiao; William H Westra; Andy Trotti; Sharon Spencer; Jonathan Harris; Christine H Chung; K Kian Ang
Journal:  J Clin Oncol       Date:  2012-05-07       Impact factor: 44.544

10.  Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.

Authors:  Nai-Ming Cheng; Joseph Tung-Chieh Chang; Chung-Guei Huang; Din-Li Tsan; Shu-Hang Ng; Hung-Ming Wang; Chun-Ta Liao; Chien-Yu Lin; Cheng-Lung Hsu; Tzu-Chen Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-02       Impact factor: 9.236

View more
  5 in total

1.  Discrimination of HPV status using CT texture analysis: tumour heterogeneity in oropharyngeal squamous cell carcinomas.

Authors:  Ji Young Lee; Miran Han; Kap Seon Kim; Su-Jin Shin; Jin Wook Choi; Eun Ju Ha
Journal:  Neuroradiology       Date:  2019-10-22       Impact factor: 2.804

2.  Defining the Prevalence and Prognostic Value of Perineural Invasion and Angiolymphatic Invasion in Human Papillomavirus-Positive Oropharyngeal Carcinoma.

Authors:  William G Albergotti; Hannah L Schwarzbach; Shira Abberbock; Robert L Ferris; Jonas T Johnson; Umamaheswar Duvvuri; Seungwon Kim
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

3.  Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.

Authors:  Boeun Lee; Young Jun Choi; Seon Ok Kim; Yoon Se Lee; Jung Yong Hong; Jung Hwan Baek; Jeong Hyun Lee
Journal:  Korean J Radiol       Date:  2019-08       Impact factor: 3.500

4.  Radiological differences in computed tomography findings and texture analysis between cystic lymph node metastases of human papillomavirus-positive oropharyngeal cancer and second branchial cysts.

Authors:  Akira Baba; Hisashi Kessoku; Ryo Kurokawa; Hideomi Yamauchi; Taisuke Akutsu; Eiji Shimura; Koshi Ikeda; Hiroya Ojiri
Journal:  Pol J Radiol       Date:  2021-03-25

5.  Prognostic Value of Apparent Diffusion Coefficient in Oropharyngeal Carcinoma.

Authors:  Heli J Sistonen; Katri Aro; Timo Atula; Lauri Jouhi; Riikka Lindén; Laura Tapiovaara; Venla Loimu; Antti Markkola
Journal:  Clin Neuroradiol       Date:  2021-04-20       Impact factor: 3.649

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.